
Decoding the language of delivery @labcentral https://xitter.cf/t.co/B9QmLir5yh
Joined February 2022
- Tweets16
- Following67
- Followers58
- Likes12
We are excited to announce that Gensaic has entered into a partnership with @novonordisk!
Read more about our partnership here:
businesswire.com/news/home/2…
gensaic retweeted
Why gene therapies must go virus-free: Why is #genetherapy so costly when #mRNA #vaccines are so cheap? Non-viral delivery of mRNA to the cytoplasm is now routine; non-viral delivery of DNA to the nucleus isn't - but may soon be. Just out in @NatureBiotech rdcu.be/dezRc
Catch our team at #ASGCT23! We’re looking forward to learning and discussing the newest developments in gene therapy.
gensaic retweeted
Neuroscience is on the cusp of a paradigm shift in the delivery of genetic materials to the brain. @GensaicBio has pioneered a world-leading delivery platform, and @OvidRx was proud to help kick-start this critical step in healing diseases of the brain. biocentury.com/article/64704…
gensaic retweeted
We are investing up to $3.5M in Gensaic Inc. to conduct preclinical research to develop a new approach to deliver a gene therapy to the lung cells of people with #cysticfibrosis.
on.cff.org/3ZmCu36
Gensaic has received funding from the @CF_Foundation to help us develop our gene therapy platform for CF! We are highly appreciative and excited about this opportunity to work on this severe disease.
lnkd.in/eDRhm935
gensaic retweeted
And the results are in! Congratulations to @futurefieldsHQ and @GensaicBio on securing this year’s @novonordisk Golden Ticket! #WhereBiotechBegins
Announcing a strategic collaboration with Ovid Therapeutics (@OvidRx) to develop our phage-derived gene delivery platform for rare genetic CNS diseases. The collaboration entails up to 3 therapeutic programs and completes a $5M equity investment.
eurekalert.org/news-releases…
Catch our team members @simontphd and Maggie Lejeune at #phagefutures today and tomorrow!
Our co-founder Amin Hajitou just published a paper using engineered phage-derived particles (PDPs) for cancer immunotherapy: embopress.org/doi/full/10.15… .../
These engineered PDPs carrying IL-12, IL-15, and TNFa showed effective targeted delivery to tumors in vivo, followed by reductions in tumor size and increased survival.../
The inherent modularity of the phage platform offers the possibility of greatly expanding the repertoire of targeting and DNA cargos. Learn more at gensaic.com
We're hiring a research associate to join our team! Please apply at the link: linkedin.com/jobs/view/31234…







